Method of using catalpic acid to treat dyslipidemia
US8084500B2 · kind B2 · utility
0Cited by
5References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 15, 2008 |
| Grant date | Dec 27, 2011 |
| Priority date | — |
| Expiry date | May 6, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/202
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating and preventing dyslipidemia, cardiovascular disease, type 2 diabetes, obesity and other diseases associated with the Metabolic Syndrome and of increasing the expression of genes that promote lipid oxidation in an animal, including mammals and humans, in which a therapeutically effective amount of catalpic acid is administered orally or parenterally to the animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.